A CDC-led study published in the American Journal of Preventive Medicine used linked electronic health records and pharmacy dispensing data from Truveta to analyze 4,027,607 antihypertensive prescriptions among 936,502 US adults with hypertension. Compared with 7 am...
Nearly 8% of all prescriptions in March 2026 were for GLP-1 RAs, following the largest quarter-over-quarter percentage point increase in overall GLP-1 RA prescribing observed since the study began in 2019. First-time anti-obesity medication (AOM) prescribing increased...
Authors: Karen G Farrar ⊕Truveta, Inc, Bellevue, WA, Duy Do ⊕Truveta, Inc, Bellevue, WA, Nina B Masters ⊕Truveta, Inc, Bellevue, WA, Brianna M Cartwright ⊕Truveta, Inc, Bellevue, WA After CVS Caremark made anti-obesity semaglutide the preferred formulary option in...
Estrogen-based hormone replacement therapy (HRT) prescribing more than doubled from 2018 to 2026. The largest increases were seen in patches and vaginal creams, with patch use more than tripling and vaginal cream use increasing more than fourfold. The rates of women...
